CSSI Funding Opportunities
Find active funding opportunities for research programs coordinated by the Center for Strategic Scientific Initiatives (CSSI) to support research and technologies to enhance cancer detection and screening, clinical diagnosis, treatment, control, epidemiology, and health disparities.
| Program | Title | Announcement Number | Opening Date | Expiration Date | Activity Code |
|---|---|---|---|---|---|
| IMAT | Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) | RFA-CA-24-008 | 03/01/2024 | 10/02/2024 | R61 |
| IMAT | Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) | RFA-CA-24-009 | 03/01/2024 | 10/02/2024 | R33 |
| IMAT | Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) | RFA-CA-24-010 | 03/01/2024 | 10/02/2024 | R61 |
| IMAT | Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) | RFA-CA-24-011 | 03/01/2024 | 10/02/2024 | R33 |
| IMAT | Revision Applications for Incorporation of Novel NCI-supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) | RFA-CA-24-012 | 03/01/2024 | 10/02/2024 | R01 (revision) |
| IMAT | Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) | RFA-CA-24-013 | 03/01/2024 | 10/02/2024 | U01 (revision) |
| IMAT | Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) | RFA-CA-24-014 | 03/01/2024 | 10/02/2024 | P50 (revision) |
| IMAT | Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P30 Clinical Trial Optional) | RFA-CA-24-015 | 03/01/2024 | 10/02/2024 | P30 (revision) |
| ITCR | Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional) | RFA-CA-24-016 | 05/11/2023 | 11/16/2024 | R21 |
| ITCR | Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) | RFA-CA-24-017 | 05/11/2023 | 11/16/2024 | U01 |
| ITCR | Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) | RFA-CA-24-018 | 05/11/2023 | 11/16/2024 | U24 |
| ITCR | Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) | RFA-CA-24-019 | 05/11/2023 | 11/16/2024 | U24 |
| N/A | Notice of Special Interest (NOSI): Technology Development for Cancer Control and Population Science Research | NOT-CA-23-037 | 03/01/2023 | 12/31/2024 | N/A |
| N/A | Notice of Special Interest (NOSI): Technologies and Informatics Tools for Cancer Metabolomics | NOT-CA-22-083 | 06/14/2022 | 12/31/2024 | N/A |